07 Jan 2001

Carvomin® Magentropfen (Carvomin® Magentropfen mit Pomeranze Lösung) - Deutschland

Updated: 07 Jan 2001

Carvomin® Magentropfen mit Pomeranze

Dyspeptische Beschwerden wie Völlegefühl, Blähungen, Aufstoßen.

Carvomin® Magentropfen Description, Presentation and Dosage

Carvomin® Magentropfen Description

Carvomin® Magentropfen Drug Class Description


Carvomin® Magentropfen Drug Description

100 g enth.: Pomeranzenschalentinktur (DAB) 80 g.

Carvomin® Magentropfen Generic Name

Carvomin® Magentropfen mit Pomeranze Lösung

Carvomin® Magentropfen Presentation

Carvomin® Magentropfen Presentation

Carvomin® Magentropfen mit Pomeranze

Carvomin® Magentropfen Manufacturer


Related Learning Zones

Bedwetting Knowledge Centre and CME

Bedwetting Knowledge Centre and CME

The Bedwetting Knowledge Centre, independently reviewed for clinical accuracy by Søren Rittig, MD, DMSc, aims to equip healthcare professionals with the information and guidance they need to effectively diagnose, treat and refer patients with nocturnal enuresis. This mobile-optimised resource contains disease awareness information, best practice guidelines and a CME activity ‘Case Studies in Urology: Best Practice Management of Bedwetting’.



The COPD Knowledge Centre has been designed to provide healthcare professionals with free access to educational materials and disease awareness information. This includes information on the epidemiology, pathophysiology and symptoms of COPD and the latest guidelines for the diagnosis, treatment and management of the disease.

COPD-specific resources such as videosguidelinesinfographics, materials for your patients, upcoming events, useful websites and symposium videos and materials from ATS 2014 and ATS 2015 are available free of charge.

Carvomin® Magentropfen Dosage

Carvomin® Magentropfen Adult Dosage


Carvomin® Magentropfen Precautions, Reactions and Contraindications

Carvomin® Magentropfen Special Precautions

Related Drugs - Gastroenterology

Back to top